The best indicator for Nike, Inc. (NKE)
We backtested 20 indicators across daily, weekly and hourly charts on real Nike, Inc. (NKE) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Nike, Inc. (NKE) over ~45.7 years — trailing buy-and-hold by 2.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Weekly | 11.8% | 0.55 | -64.1% | 50.0% | 18 | -2.1% |
| 2 | Money Flow Index ✓ | Daily | 9.4% | 0.51 | -59.8% | 80.4% | 46 | -4.3% |
| 3 | EMA 50/200 Cross ✓ | Daily | 9.8% | 0.5 | -64.5% | 50.0% | 28 | -4.0% |
| 4 | SMA 50/200 Cross ✓ | Daily | 9.6% | 0.49 | -63.2% | 53.3% | 30 | -4.1% |
| 5 | MACD ✓ | Weekly | 9.0% | 0.49 | -68.1% | 53.8% | 91 | -4.9% |
| 6 | EMA 20/50 Cross ✓ | Daily | 8.2% | 0.45 | -70.3% | 41.8% | 98 | -5.6% |
| 7 | Donchian Midline ✓ | Weekly | 7.8% | 0.44 | -61.1% | 50.0% | 118 | -6.0% |
| 8 | ADX / DMI ✓ | Daily | 6.7% | 0.43 | -48.0% | 42.2% | 313 | -7.0% |
| 9 | Donchian Midline ✓ | Daily | 7.4% | 0.42 | -70.1% | 40.4% | 623 | -6.4% |
| 10 | Bollinger Breakout ✓ | Weekly | 5.9% | 0.41 | -50.1% | 54.8% | 42 | -8.0% |
| 11 | Donchian Breakout ✓ | Weekly | 6.5% | 0.4 | -51.5% | 51.4% | 37 | -7.3% |
| 12 | RSI Trend (>50) | Daily | 6.7% | 0.39 | -66.3% | 36.9% | 612 | -7.0% |
| 13 | RSI Trend (>50) ✓ | Weekly | 6.8% | 0.39 | -71.9% | 43.3% | 120 | -7.1% |
| 14 | Rate of Change ✓ | Weekly | 6.4% | 0.38 | -72.1% | 49.3% | 138 | -7.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Nike, Inc. (NKE), EMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.